Skip to content

SupporTive Care At Home Research for Patients with Progressive Neurologic Disease Patients (STAHR-Neuro) (HOMECARE)

SupporTive Care At Home Research : Single-center, Single-arm, Investigator-initiated Exploratory Clinical Trial for Patients with Neurologic Disease Patients

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06663514
Enrollment
30
Registered
2024-10-29
Start date
2022-08-23
Completion date
2026-05-31
Last updated
2024-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Supportive Care

Brief summary

To test the effects of home-based care on healthcare utilization within one Year (Hospitalization Status, Number of Hospitalizations, Unplanned Hospitalization Status, Number of Unplanned Hospitalizations, Length of Hospital Stay, Number of Emergency Room Visits, Number of Outpatient Visits) among progressive neurologic disease patients with decreased performance status. Home-based care includes education for patients and their family caregivers, home visits by specialized home-based medical staff, and regular status check-ups.

Detailed description

This study is a Single-center, single-arm, investigator-initiated exploratory clinical trial to test the effects of home-based care on Healthcare Utilization within One Year (Hospitalization Status, Number of Hospitalizations, Unplanned Hospitalization Status, Number of Unplanned Hospitalizations, Length of Hospital Stay, Number of Emergency Room Visits, Number of Outpatient Visits)among neurologic disease Patients with decreased performance status. Home-based care includes education for patients and their family caregivers, home visits by specialized home-based medical staff, and regular status check-up. Study participants are recruiting from single institutions, aiming for 30 progressive neurologic disease patients.

Interventions

OTHERSupporTive Care At Home

Home-based medical care is based on a specialized home-based medical team approach, including following: Specialized Home-Based Medical Team Approach Initial Assessment and Education Initial Home Visits and Education Multidisciplinary Team Meeting Regular Assessment After the Initial Visit

Sponsors

BeLong Cho
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Both the patient and their family caregiver must meet the criteria to be considered for this research. Patient Diagnosis of Progressive Neurological Disorders (Motor Neuron Disease, Parkinson's Disease) with ICD-10 codes (G12.2, G20, G11.9, G21, G22, G23, G30.8, G31.8, F02.3, etc.), additional diseases can be included depending on the patient's condition. Individuals with a modified Rankin Score (mRS) of 3-5 A person who wishes to stay at home A person whose family caregiver resides at home A person who wishes to participate in the research Family Caregiver A family\* member of the patient \* Family: refers to the patient's spouse (including a common-law partner), descendants and their spouses up to the second degree, siblings and their spouses, and relatives and their spouses up to the eighth degree. A person who meets one of the following conditions: Lives with the patient (patient's household member) Does not live with the patient, but visits the patient's home more than three times a week A person who wants the patient to stay at home A person who can communicate easily with medical staff A person who wishes to participate in the research

Exclusion criteria

* If either the patient or the family caregiver meets any one of these criteria, they are excluded from the study. Patient A person who cannot speak, hear, or read Korean A person who is judged by a medical doctor to be unable to take part in this research due to extremely poor health A person residing outside the range that can be visited by the respective medical institution (the conditions for distance are to be specified by each medical institution)\* \* This condition is not applicable for the control group. A person who has used hospital- or home-type hospice and palliative care services A person who is under the age of 19 Family Caregiver A person who cannot speak, hear, or read Korean A person who is judged by a medical doctor to be unable to take part in this research due to extremely poor health A person under the age of 19

Design outcomes

Primary

MeasureTime frameDescription
Unplanned hospitalizationwithin One Yearadmission to the enrolled hospital to treat unexpected symptoms or medical conditions (not including planned admission for chemotherapy or admission for planned surgery or intervention) admission to a hospital other than the enrolled hospital admission to a nursing hospital for a duration of less than 4 weeks.

Secondary

MeasureTime frameDescription
Hospitalizationwithin 12 months following enrollmentthe number of hospitalization
ER visitswithin 12 months following enrollmentthe number of emergency room visits
Healthcare usewithin 12 months following enrollmentthe number of healthcare use for severe diseases
Patient end-of-life care: ICU admissionwithin 1 month before deathICU admission one month before death
Patient end-of-life care: ventilator treatmentwithin 1 month before deathMechanical ventilator apply one month before death
Patient end-of-life care: an advance directivewithin 1 month before deathCompletion of advance medical directives within 1 month before death
symptom managementwithin 12 months following enrollmentIPOS-neuro S8 of patient
Patient medical utilizationwithin 12 months following enrollmentThe total number of hospital utilization, including hospitalization, emergency room visit, and clinic visits
Satisfaction with services (patient)within 12 months following enrollmentSatisfaction of the study participant (patient) with the service in this study, evaluated by questionnaire
Quality of life of family caregiverwithin 12 months following enrollmentEuro-Quality of Life-5 Dimension (EQ-5D) of family caregiver
Care burden of family caregiverwithin 12 months following enrollmentThe Korean version of Caregiver Reaction Assessment (CRA-K) of family caregiver
Depressive symptom of family caregiverwithin 12 months following enrollmentPatient Health Questionnaire-9 (PHQ-9) of family caregiver
Caring competency of family caregiverwithin 12 months following enrollmentCaring competency of family caregiver, measured by questionnaire
Satisfaction with services (family caregiver)within 12 months following enrollmentSatisfaction of the study participant (family caregiver) with the service in this study, evaluated by questionnaire
Expenseswithin 12 months following enrollmentmedical expenses, care expenses
Quality of life of patient - EQ-5Dwithin 12 months following enrollmentEuro-Quality of Life-5 Dimension (EQ-5D) of patient

Countries

South Korea

Contacts

Primary ContactAhhyun Lee
leeahyun502@snu.ac.kr82-10-7280-8256

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026